Skip to main content
. 2013 Jun 24;2013:583891. doi: 10.1155/2013/583891

Table 2.

Type I and II endometrial cancers.

Type I endometrial cancers Type II endometrial cancers
Hormonal impact Estrogen dependent Estrogen independent
Histology Endometrioid adenocarcinomas Clear-cell, serous, uterine carcinosarcomas
Patient population Younger, obese, perimenopausal Older, thin, postmenopausal
Distribution 85% 15%
Prognosis Better differentiated More aggressive, proportionally higher mortality
Genetic mutations Kras, PTEN, MLH1 p53, erbB2